|
C6ORF57 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.646660E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.34959999999562E-05 |
| Normal-vs-Stage2 |
3.096200E-02 |
| Normal-vs-Stage3 |
2.652100E-02 |
| Normal-vs-Stage4 |
1.420310E-02 |
| Stage1-vs-Stage2 |
3.757400E-01 |
| Stage1-vs-Stage3 |
4.078200E-01 |
| Stage1-vs-Stage4 |
6.835000E-01 |
| Stage2-vs-Stage3 |
9.267000E-01 |
| Stage2-vs-Stage4 |
7.938000E-01 |
| Stage3-vs-Stage4 |
8.678200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.958100E-04 |
| Normal-vs-AfricanAmerican |
7.302700E-03 |
| Normal-vs-Asian |
3.883600E-02 |
| Caucasian-vs-AfricanAmerican |
6.646000E-01 |
| Caucasian-vs-Asian |
3.879600E-01 |
| AfricanAmerican-vs-Asian |
2.383200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.763110E-04 |
| Normal-vs-Female |
3.363000E-03 |
| Male-vs-Female |
4.242400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.243100E-03 |
| Normal-vs-Extreme_Weight |
9.53179999999554E-05 |
| Normal-vs-Obese |
2.595200E-03 |
| Normal-vs-Extreme_Obese |
4.605500E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.679200E-01 |
| Normal_Weight-vs-Obese |
7.062200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.474200E-01 |
| Extreme_Weight-vs-Obese |
1.492200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.605600E-01 |
| Obese-vs-Extreme_Obese |
5.697600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.754420E-01 |
| Normal-vs-Age(41-60Yrs) |
2.662500E-03 |
| Normal-vs-Age(61-80Yrs) |
8.235400E-04 |
| Normal-vs-Age(81-100Yrs) |
5.798500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.915800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.744400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.069200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.298200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.233800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.292800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.224970E-03 |
| Normal-VS-Type2 PRCC |
1.411730E-02 |
| Normal-VS-KIRP CIMP |
6.288100E-02 |
| Normal-VS-Unclassified PRCC |
5.995000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.830390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.617800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.464200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.359600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.843600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.363800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.856540E-03 |
| Normal-vs-N1 |
5.173900E-02 |
| Normal-vs-N2 |
7.393600E-02 |
| N0-vs-N1 |
4.242800E-01 |
| N0-vs-N2 |
6.759800E-01 |
| N1-vs-N2 |
4.202600E-01 |
|
|
